Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Perry

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 2015
Survival outcomes in elderly patients with glioblastomaD S Tsang, L Khan, J R Perry, et al.
Radiology|December 1, 1995
Interpretation time of serial chest CT examinations with stacked-metaphor workstation versus film alternatorD V Beard, P L Molina, K E Muller, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Impact of a novel prioritization framework on clinician-led oncology drug submissionsJ Keech, J Beca, A Eisen, et al.
Neurology|October 27, 1997
Challenges in the design and conduct of phase III brain tumor therapy trialsJ R Perry, L M DeAngelis, S C Schold, et al.
Journal of Thrombosis and Haemostasis : JTH|July 6, 2010
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant gliomaJ R Perry, J A Julian, N J Laperriere, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 2015
Survival outcomes in elderly patients with glioblastomaD S Tsang, L Khan, J R Perry, et al.
Radiology|December 1, 1995
Interpretation time of serial chest CT examinations with stacked-metaphor workstation versus film alternatorD V Beard, P L Molina, K E Muller, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Impact of a novel prioritization framework on clinician-led oncology drug submissionsJ Keech, J Beca, A Eisen, et al.
Neurology|October 27, 1997
Challenges in the design and conduct of phase III brain tumor therapy trialsJ R Perry, L M DeAngelis, S C Schold, et al.
Journal of Thrombosis and Haemostasis : JTH|July 6, 2010
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant gliomaJ R Perry, J A Julian, N J Laperriere, et al.
Pageof 7